Literature DB >> 11306951

SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells.

T J Lin1, T B Issekutz, J S Marshall.   

Abstract

BACKGROUND: Mast cell numbers and expression of chemokines are known to increase in the context of angiogenesis and inflammation, but the mechanisms by which this occurs are not understood. Stromal-derived factor-1 (SDF-1) is an important chemokine in angiogenesis and cell migration. The effects of SDF-1 on human mast cells were examined.
METHODS: Expression of the SDF-1 receptor CXC chemokine receptor 4 (CXCR4) on mast cells was examined by RT-PCR and flow cytometry. The ability of labeled cord blood-derived mast cells to migrate across HUVEC monolayers in response to SDF-1 was determined. The cytokine and chemokine responses of cord blood-derived mast cells to SDF-1 treatment over 24 h were examined by ELISA.
RESULTS: Cord blood-derived human mast cells expressed the CXCR4 receptor for SDF-1 and migrated across HUVEC monolayers in response to this chemokine. Treatment of cord blood-derived mast cells with SDF-1 did not induce degranulation or the production of several cytokines but did induce a highly selective IL-8 response.
CONCLUSION: Human mast cells can both migrate across vascular endothelium and produce the pro-angiogenic chemokine IL-8 in response to SDF-1. These responses may be important in angiogenic processes. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306951     DOI: 10.1159/000053693

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  10 in total

1.  Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2.

Authors:  J Pablo Abonia; K Frank Austen; Barrett J Rollins; Sunil K Joshi; Richard A Flavell; William A Kuziel; Pandelakis A Koni; Michael F Gurish
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

2.  RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.

Authors:  Geetanjali Bansal; Jeffrey A DiVietro; Hye Sun Kuehn; Sudhir Rao; Karl H Nocka; Alasdair M Gilfillan; Kirk M Druey
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

3.  Subcutaneous plasmacytoma metastasis precipitated by tunneled central venous catheter insertion.

Authors:  Ron C Gaba; John P Kenny; Pawan Gundavaram; Jeremy R Katz; Liza R Aquino Escuadro; Sujata Gaitonde
Journal:  Case Rep Oncol       Date:  2011-06-30

4.  Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.

Authors:  Hui Zhang; Huanwen Wu; Jian Guan; Li Wang; Xinyu Ren; Xiaohua Shi; Zhiyong Liang; Tonghua Liu
Journal:  Oncotarget       Date:  2015-02-20

5.  The SDF-1α3'A genetic variation is correlated with susceptibility of asthma in Iranian patients.

Authors:  Houshang Rafatpanah; Masoud Amin; Mohsen Ghasemshirazi; Mohammad Kazemiarababadi; Hossein Khorramdelazad; Hamid Abousaidi; Ziba Shabani; Ahmadreza Sayadi; Gholamhossein Hassanshahi; Jamile Samadi
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

Review 6.  Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration.

Authors:  Hyunyun Kim; Sujin Kim; Sang Hong Baek; Sang-Mo Kwon
Journal:  Stem Cells Int       Date:  2016-12-20       Impact factor: 5.443

Review 7.  Are Mast Cells MASTers in Cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Giancarlo Marone; Raffaella Iannone; Gianni Marone; Francescopaolo Granata
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 7.561

8.  SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception.

Authors:  Ivanka Dimova; Swapna Karthik; Andrew Makanya; Ruslan Hlushchuk; David Semela; Vladislav Volarevic; Valentin Djonov
Journal:  J Cell Mol Med       Date:  2019-04-04       Impact factor: 5.310

9.  Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis.

Authors:  Maria Mirabelli; Eusebio Chiefari; Luigi Puccio; Daniela Patrizia Foti; Antonio Brunetti
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

10.  The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.

Authors:  Yi-fang Ping; Xiao-hong Yao; Jian-hong Chen; Hong Liu; Dai-lun Chen; Xiang-dong Zhou; Ji Ming Wang; Xiu-wu Bian
Journal:  J Neurooncol       Date:  2007-04-06       Impact factor: 4.506

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.